“…Hence, the reported vaccine acceptance or hesitancy was mostly assessed using hypothetical questions as there were still no vaccines available outside of the clinical trial setting [3][4][5][6][8][9][10]. Several cross-sectional studies have since explored COVID-19 vaccine acceptance and hesitancy and their determinants after the respective countries' vaccination program implementation, namely in European countries [2], such as the United Kingdom [15,16,20,21], Germany [15,22], Denmark [15,23], France [15], Hungary [15], Sweden [15], Italy [15], Norway [21], Poland [24], the Netherlands [25], Spain [26] and Greece [27]. Additional studies were also conducted in Saudi Arabia [28], the United States of America [13,17,21,29], South Africa [21,30], Jordan [31], Israel [32], Chile [33], China [18,21,34,35], Japan [21,36] and Australia [21], among others [21].…”